Chirfi Guindo - 30 Apr 2024 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role
Chief Marketing Officer
Signature
/s/ Kelly Grez, as attorney-in-fact for Mr. Chirfi Guindo
Issuer symbol
MRK
Transactions as of
30 Apr 2024
Transactions value $
$0
Form type
4
Filing time
02 May 2024, 16:22:17 UTC
Previous filing
04 Aug 2023
Next filing
06 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MRK Common Stock 20.8K 30 Apr 2024 Direct F1
holding MRK Common Stock-401(k) Plan 53.5 30 Apr 2024 By 401(k) F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRK Stock Option (Right to Buy) Award $0 +29.3K $0.00 29.3K 30 Apr 2024 Common Stock 29.3K $129.22 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Holdings include shares acquired in dividend reinvestment transactions.
F2 Includes shares acquired and dividends earned through April 5, 2024 in the Merck U.S. Savings Plan, a 401(k) plan.
F3 The option vests and becomes exercisable in equal installments on 4/30/2025, 4/30/2026 and 4/30/2027.